This online educational program provides a practical framework for optimizing anemia management in patients with lower-risk MDS. Expert faculty examine how clinical and molecular factors can guide treatment sequencing, including consideration of emerging therapies and clinical trials, while addressing proactive monitoring and management of class-specific toxicities. The program also explores when earlier intervention may be warranted based on factors such as worsening symptoms, increasing transfusion burden, declining functional status, and persistent reductions in hemoglobin.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Address:
- 1301 Virginia Drive
Pricing
CME included with membership
| Free Registration | Free |
| Tufts-Affiliated HCP - Early Bird (by 10/5/26) | $75 |
| Tufts-Affiliated HCP - Standard | $175 |
| Trainees & Allied Health - Early Bird (by 10/5/26) | $75 |
| Trainees & Allied Health - Standard | $175 |
| Physicians - Early Bird (by 10/5/26) | $150 |
+3 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Neurology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- Commercial Support
-
Available fromOct 30, 2026
-
Last day to claim creditOct 31, 2027 1 year left
-
Answers in CME Inc. (AiCME) Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy
-
Plexus Communications +1 Practice-Changing Insights and Implementation Strategies in LR-MDS
-
Medical Learning Institute, Inc. Nursing Perspectives in Myelodysplastic Syndromes: Risk-Adapted Therapy and Symptom Management
-
Global Learning Collaborative Beyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies
-
Global Learning Collaborative Treatment Decisions That Matter: A Case-Based Discussion in Advanced Ovarian Cancer
-
Global Learning Collaborative The Frontline Imperative: Integrating Anti-CD38 Based Regimens Into Multiple Myeloma Care in Community Practice
